Here is a curated list of the largest global drug discovery companies by revenue. The companies on this list have a significant focus on developing innovative new chemical and biological entities (though some have divisions that deal with generics, distribution, etc.). If you think there’s a company missing that should be included, please contact us.
This does not currently include pre-revenue companies. Good sources for pre-revenue biotech companies are the Nasdaq’s biotechnology index components, Brad Loncar’s site, Bay Bridge Bio’s site, and specialist investor portfolios.
Company Name | Public or Private | Company Headquarters Country (2 Letter) | Revenue (2019, $B) |
---|---|---|---|
Johnson & Johnson | Public | US | 81.6 |
Roche | Public | CH | 58.1 |
Pfizer | Public | US | 53.6 |
Novartis | Public | CH | 53.2 |
Bayer | Public | DE | 46.7 |
Merck & Co | Public | US | 42.3 |
Sanofi | Public | FR | 42.1 |
GlaxoSmithKline | Public | UK | 41.1 |
AbbVie | Public | US | 32.8 |
Eli Lilly | Public | US | 24.6 |
Boehringer Ingelheim | Private | DE | 23.9 |
Amgen | Public | US | 23.7 |
Bristol-Myers Squibb | Public | US | 22.6 |
Gilead | Public | US | 22.1 |
AstraZeneca | Public | UK | 22.1 |
Teva | Public | IL | 18.9 |
Novo Nordisk | Public | DK | 17.7 |
Merck KGaA | Public | DE | 17.5 |
Takeda | Public | JP | 16 |
Celgene (BMS) | Public | US | 15.3 |
Biogen | Public | US | 13.5 |
Astellas | Public | JP | 11.8 |
Otsuka | Public | JP | 11.7 |
Daiichi Sankyo | Public | JP | 8.7 |
Teijin | Public | JP | 7.6 |
Regeneron | Public | US | 6.7 |
UCB | Public | EU | 5.5 |
Eisai | Public | JP | 5.4 |
Servier | Private | FR | 4.9 |
Menarini | Private | IT | 4.3 |
Sumitomo Dainippon | Public | JP | 4.2 |
Alexion | Public | US | 4.1 |
Mitsubishi Tanabe | Public | JP | 3.9 |
Kyowa Kirin | Public | JP | 3.1 |
Shionogi | Public | JP | 3.1 |
Vertex | Public | US | 3 |
Lundbeck | Public | DK | 2.9 |
Ipsen | Public | FR | 2.8 |
Pierre Fabre | Private | FR | 2.6 |
Jiangsu Hengrui | Public | CN | 2.6 |
Taisho | Public | JP | 2.5 |
Ono | Public | JP | 2.4 |
Lupin | Public | IN | 2.3 |
Ferring | Private | CH | 2.3 |
Sino Biopharm | Public | HK | 2.2 |
Seagen | Public | US | 2.2 |
Chiesi | Private | IT | 1.9 |
Jazz Pharma | Public | IE | 1.9 |
Angelini | Private | IT | 1.9 |
Incyte | Public | US | 1.9 |
Cadila | Public | IN | 1.8 |
Kelun Biotech | Public | CN | 1.7 |
Gedeon Richter | Public | HU | 1.7 |
LEO Pharma | Private | DK | 1.6 |
United Therapeutics | Public | US | 1.6 |
Hisun | Public | CN | 1.6 |
BioMarin | Public | US | 1.5 |
Grünenthal | Private | DE | 1.5 |
Yuhan | Public | KR | 1.4 |
Hisamitsu | Public | JP | 1.3 |
Glenmark | Public | IN | 1.3 |
Green Cross Holdings | Public | KR | 1.3 |
Livzon | Public | CN | 1.3 |
Horizon Pharma | Public | IE | 1.2 |
AlfaSigma | Private | IT | 1.2 |
Orion | Public | FI | 1.2 |
Merz | Private | DE | 1.2 |
Hanmi Pharma | Public | KR | 0.78 |